Nephros (NEPH) Common Equity (2016 - 2025)
Historic Common Equity for Nephros (NEPH) over the last 17 years, with Q3 2025 value amounting to $10.0 million.
- Nephros' Common Equity rose 2241.25% to $10.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.0 million, marking a year-over-year increase of 2241.25%. This contributed to the annual value of $8.6 million for FY2024, which is 271.6% up from last year.
- Nephros' Common Equity amounted to $10.0 million in Q3 2025, which was up 2241.25% from $9.6 million recorded in Q2 2025.
- In the past 5 years, Nephros' Common Equity registered a high of $15.5 million during Q1 2021, and its lowest value of $7.9 million during Q2 2024.
- Its 5-year average for Common Equity is $10.6 million, with a median of $9.3 million in 2025.
- In the last 5 years, Nephros' Common Equity surged by 3400.35% in 2021 and then plummeted by 3978.57% in 2022.
- Nephros' Common Equity (Quarter) stood at $14.7 million in 2021, then plummeted by 39.79% to $8.9 million in 2022, then fell by 5.89% to $8.4 million in 2023, then rose by 2.72% to $8.6 million in 2024, then increased by 16.55% to $10.0 million in 2025.
- Its last three reported values are $10.0 million in Q3 2025, $9.6 million for Q2 2025, and $9.3 million during Q1 2025.